X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3567) 3567
klebsiella pneumoniae - enzymology (3173) 3173
microbiology (3006) 3006
index medicus (2867) 2867
beta-lactamases - genetics (2080) 2080
klebsiella-pneumoniae (1975) 1975
microbial sensitivity tests (1908) 1908
anti-bacterial agents - pharmacology (1812) 1812
infectious diseases (1763) 1763
escherichia-coli (1614) 1614
escherichia coli - enzymology (1554) 1554
beta-lactamases - metabolism (1533) 1533
klebsiella pneumoniae - genetics (1481) 1481
klebsiella pneumoniae - drug effects (1395) 1395
pharmacology & pharmacy (1336) 1336
klebsiella infections - microbiology (1283) 1283
enterobacteriaceae (1260) 1260
male (1137) 1137
klebsiella pneumoniae - isolation & purification (1134) 1134
beta-lactamases - biosynthesis (1090) 1090
female (1057) 1057
bacterial proteins - genetics (1017) 1017
resistance (966) 966
enterobacteriaceae - enzymology (934) 934
escherichia coli - genetics (899) 899
molecular sequence data (895) 895
bacteria (847) 847
escherichia coli - drug effects (816) 816
bacterial proteins - metabolism (771) 771
middle aged (753) 753
klebsiella pneumoniae (738) 738
biochemistry & molecular biology (715) 715
epidemiology (702) 702
aged (700) 700
prevalence (698) 698
enterobacteriaceae infections - microbiology (674) 674
klebsiella infections - epidemiology (662) 662
biochemical phenomena, metabolism, and nutrition (642) 642
plasmids (630) 630
escherichia coli - isolation & purification (625) 625
beta-lactam resistance (603) 603
amino acid sequence (590) 590
adult (587) 587
klebsiella - enzymology (578) 578
escherichia coli (575) 575
cross infection - microbiology (574) 574
polymerase chain reaction (569) 569
bacterial infections and mycoses (568) 568
genes (560) 560
escherichia coli infections - microbiology (558) 558
kinetics (556) 556
research article (531) 531
enterobacteriaceae - drug effects (520) 520
polycyclic compounds (513) 513
anti-bacterial agents - therapeutic use (504) 504
enzymes (503) 503
dna, bacterial - genetics (493) 493
hospitals (491) 491
base sequence (486) 486
emergence (475) 475
klebsiella (472) 472
molecular epidemiology (458) 458
carbapenems - pharmacology (454) 454
klebsiella infections - drug therapy (451) 451
genes, bacterial (448) 448
drug resistance, bacterial (446) 446
animals (434) 434
sequence analysis, dna (424) 424
infections (421) 421
research (420) 420
drug resistance, multiple, bacterial (413) 413
enterobacteriaceae - isolation & purification (412) 412
cross infection - epidemiology (405) 405
electrophoresis, gel, pulsed-field (404) 404
genotype (404) 404
plasmids - genetics (401) 401
pneumonia (401) 401
aged, 80 and over (398) 398
beta-lactamases - secretion (396) 396
identification (393) 393
infectious disease (390) 390
antibiotics (389) 389
enterobacteriaceae - genetics (383) 383
enterobacteriaceae infections - epidemiology (365) 365
bacterial pneumonia (363) 363
risk factors (363) 363
gene (359) 359
biotechnology & applied microbiology (355) 355
outbreak (354) 354
analysis (335) 335
pseudomonas-aeruginosa (335) 335
strains (335) 335
beta-lactams - pharmacology (330) 330
cloning, molecular (330) 330
carbapenemase (323) 323
mutation (318) 318
beta-lactamases - analysis (316) 316
mechanisms of resistance (314) 314
spread (311) 311
substrate specificity (308) 308
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6209) 6209
Spanish (89) 89
Japanese (78) 78
French (64) 64
Russian (48) 48
Chinese (35) 35
Turkish (32) 32
German (19) 19
Polish (8) 8
Croatian (5) 5
Czech (5) 5
Portuguese (5) 5
Slovak (5) 5
Italian (4) 4
Romanian (4) 4
Korean (3) 3
Ukrainian (3) 3
Danish (2) 2
Lithuanian (2) 2
Swedish (2) 2
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Respiratory Research, ISSN 1465-9921, 03/2015, Volume 16, Issue 1, p. 42
Background and purpose: The persistent influx of neutrophils into the lung and subsequent tissue damage are characteristics of COPD, cystic fibrosis and acute... 
Adhesion molecules | VAP-1/SSAO | Lung inflammation | Neutrophils | COPD | INDUCED ASTHMA | RECRUITMENT | VASCULAR ADHESION PROTEIN-1 | AIRWAY INFLAMMATION | SENSITIVE AMINE OXIDASE | CXCR2 ANTAGONIST | INDUCED LUNG INFLAMMATION | RESPIRATORY SYSTEM | IN-VIVO | INFECTION | CYSTIC-FIBROSIS | Respiratory Tract Infections - enzymology | Cell Adhesion Molecules - antagonists & inhibitors | Rhinovirus - pathogenicity | Cecum - microbiology | Picornaviridae Infections - virology | Lipopolysaccharides | Lung - enzymology | Cecum - surgery | Bronchoconstriction - drug effects | Asthma - immunology | Pneumonia - immunology | Respiratory Tract Infections - etiology | Asthma - virology | Neutrophil Infiltration - drug effects | Disease Models, Animal | Klebsiella Infections - enzymology | Asthma - physiopathology | Anti-Inflammatory Agents - pharmacology | Pneumonia - enzymology | Asthma - enzymology | Allylamine - analogs & derivatives | Enzyme Inhibitors - pharmacology | Lung - physiopathology | Cell Adhesion Molecules - metabolism | Picornaviridae Infections - enzymology | Lung - drug effects | Respiratory Tract Infections - immunology | Picornaviridae Infections - physiopathology | Mice, Inbred BALB C | Endothelial Cells - enzymology | Leukocyte Rolling - drug effects | Rats, Wistar | Benzamides - pharmacokinetics | Picornaviridae Infections - drug therapy | Dose-Response Relationship, Drug | Ligation | Amine Oxidase (Copper-Containing) - antagonists & inhibitors | Enzyme Inhibitors - pharmacokinetics | Allylamine - pharmacology | Anti-Inflammatory Agents - pharmacokinetics | Benzamides - pharmacology | Klebsiella Infections - drug therapy | Picornaviridae Infections - immunology | Pneumonia - etiology | Mice, Inbred C57BL | Punctures | Respiratory Tract Infections - drug therapy | Klebsiella Infections - microbiology | Asthma - drug therapy | Amine Oxidase (Copper-Containing) - metabolism | Endothelial Cells - immunology | Animals | Pneumonia - drug therapy | Klebsiella Infections - immunology | Klebsiella pneumoniae - pathogenicity | Allylamine - pharmacokinetics | Lung - immunology | Endothelial Cells - drug effects | Health aspects | Analysis | Endothelium | VAP-1 | SSAO | Research
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2015, Volume 59, Issue 9, pp. 5340 - 5347
Journal Article
PloS one, ISSN 1932-6203, 2015, Volume 10, Issue 3, p. e0123690
A new phenotypic test, called the Carbapenem Inactivation Method (CIM), was developed to detect carbapenemase activity in Gram-negative rods within eight... 
FLIGHT MASS-SPECTROMETRY | MULTIPLEX PCR | DESORPTION IONIZATION-TIME | PSEUDOMONAS | MULTIDISCIPLINARY SCIENCES | RESISTANCE | ACINETOBACTER | BETA-LACTAMASE GENE | RAPID DETECTION | KLEBSIELLA-PNEUMONIAE | ENTEROBACTERIACEAE | Bacterial Proteins - antagonists & inhibitors | Enterobacteriaceae - enzymology | Bacterial Proteins - genetics | Enterobacteriaceae - genetics | Pseudomonas aeruginosa - drug effects | Acinetobacter baumannii - enzymology | Sequence Analysis, DNA | Gram-Negative Bacteria - enzymology | Gram-Negative Bacteria - drug effects | Phenotype | Carbapenems - pharmacology | beta-Lactamases - genetics | Pseudomonas aeruginosa - genetics | Pseudomonas aeruginosa - enzymology | Enterobacteriaceae - drug effects | Polymerase Chain Reaction | Bacterial Proteins - metabolism | DNA, Bacterial - analysis | Anti-Bacterial Agents - pharmacology | High-Throughput Nucleotide Sequencing | Gram-Negative Bacteria - genetics | beta-Lactamases - metabolism | Acinetobacter baumannii - drug effects | Acinetobacter baumannii - genetics | Pneumonia | Oxalic acid | Computer-integrated manufacturing | Bacterial pneumonia | Analysis | Methods | Klebsiella | Enterobacter cloacae | Laboratories | Genes | Ribosomal DNA | Carbapenemase | Rods | Fermenters | Inactivation | E coli | Coding | Lasers | Bacteria | Pseudomonas aeruginosa | Gram-negative bacteria | Public health | Deactivation | Ions | Desorption | Infectious diseases | Surveillance | Plasmids | Scientific imaging | Mass spectrometry
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2014, Volume 58, Issue 2, pp. 833 - 838
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 06/2016, Volume 59, Issue 11, pp. 5377 - 5390
β-Ketoacyl-ACP synthases (KAS) are key enzymes involved in the type II bacterial fatty acid biosynthesis (FASII) pathway and are putative targets for... 
MYCOBACTERIUM-TUBERCULOSIS | CHEMISTRY, MEDICINAL | GRAM-NEGATIVE BACTERIA | DITHIOCARBONATE REARRANGEMENT | FATTY-ACID BIOSYNTHESIS | CARRIER PROTEIN SYNTHASE | POTENTIAL ANTIMALARIAL | CRYSTAL-STRUCTURE | BIOLOGICAL-ACTIVITY | ENANTIOMERIC PAIRS | MULTIDRUG-RESISTANCE | Burkholderia pseudomallei - enzymology | Staphylococcus aureus - enzymology | Klebsiella pneumoniae - drug effects | Humans | Molecular Conformation | Male | Structure-Activity Relationship | Enzyme Inhibitors - chemical synthesis | Burkholderia pseudomallei - drug effects | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase - antagonists & inhibitors | Francisella tularensis - enzymology | Anti-Bacterial Agents - chemistry | Enzyme Inhibitors - chemistry | Yersinia pestis - drug effects | Methicillin-Resistant Staphylococcus aureus - enzymology | Disease Models, Animal | Cell Line | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Enzyme Inhibitors - pharmacology | Thiophenes - pharmacology | Anti-Bacterial Agents - chemical synthesis | Thiophenes - chemical synthesis | Animals | Klebsiella pneumoniae - enzymology | Anti-Bacterial Agents - pharmacology | Mice | Staphylococcus aureus - drug effects | Thiophenes - chemistry | Francisella tularensis - drug effects | Yersinia pestis - enzymology | 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase - metabolism | Fatty Acid Biosynthesis | β-Ketoacyl ACP synthase | in vitro activity | Structure Activity Relationships | in vivo efficacy | Thiolactomycin
Journal Article
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 6, pp. 1704 - 1708
Journal Article
BMC Microbiology, ISSN 1471-2180, 04/2018, Volume 18, Issue 1, pp. 38 - 8
Background: Carbapenemases-producing Enterobacteriaceae (CPE) are a worldwide public health emergency. In Mexico, reports of CPE are limited, particularly in... 
NDM-1 | Pediatrics | OXA-232 | KPC-2 | Carbapenemase-producing Enterobacteriaceae | Mexico | OXA-48 | RESISTANT ENTEROBACTERIACEAE | INFECTIONS | ESCHERICHIA-COLI | GLOBAL DISSEMINATION | MICROBIOLOGY | TREATMENT OPTIONS | METALLO-BETA-LACTAMASE | ANTIMICROBIAL SURVEILLANCE PROGRAM | SPREAD | KLEBSIELLA-PNEUMONIAE | Klebsiella pneumoniae - isolation & purification | Carbapenem-Resistant Enterobacteriaceae - isolation & purification | Klebsiella oxytoca - genetics | Enterobacter cloacae - enzymology | Humans | Child, Preschool | Hospitals, Pediatric | Infant | Male | Microbial Sensitivity Tests | Enterobacteriaceae Infections - epidemiology | Klebsiella oxytoca - pathogenicity | Carbapenem-Resistant Enterobacteriaceae - enzymology | Carbapenem-Resistant Enterobacteriaceae - genetics | Escherichia coli - pathogenicity | Klebsiella pneumoniae - genetics | Female | beta-Lactamases - metabolism | Child | Latin America - epidemiology | Enterobacter cloacae - genetics | Escherichia coli - enzymology | Mexico - epidemiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae Infections - mortality | Genotype | Klebsiella oxytoca - isolation & purification | Enterobacteriaceae Infections - physiopathology | Enterobacter cloacae - pathogenicity | Molecular Epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Klebsiella oxytoca - enzymology | Klebsiella pneumoniae - pathogenicity | Carbapenem-Resistant Enterobacteriaceae - pathogenicity | Adolescent | Klebsiella pneumoniae - enzymology | Enterobacter cloacae - isolation & purification | Enterobacteriaceae infections | Colistin | Escherichia coli | Beta lactamases | Dosage and administration | Research | Drug therapy
Journal Article